Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition. (Q55036484)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition. |
scientific article |
Statements
Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition. (English)
1 reference
Barbara Herkert
1 reference
Audrey Kauffmann
1 reference
Sandra Mollé
1 reference
Christian Schnell
1 reference
Thomas Ferrat
1 reference
Hans Voshol
1 reference
Janina Juengert
1 reference
Hélène Erasimus
1 reference
Grégory Marszalek
1 reference
Malika Kazic-Legueux
1 reference
David Ruddy
1 reference
Mark Stump
1 reference
Daniel Guthy
1 reference
Mitko Ristov
1 reference
Keith Calkins
1 reference
Sauveur-Michel Maira
1 reference
William R Sellers
1 reference
Francesco Hofmann
1 reference
Michael N Hall
1 reference
Saskia M Brachmann
1 reference
17 November 2015
1 reference
76
1 reference
2
1 reference
390-402
1 reference
1 reference